NO20022888D0 - Nye lipopeptider som antibakterielle midler - Google Patents

Nye lipopeptider som antibakterielle midler

Info

Publication number
NO20022888D0
NO20022888D0 NO20022888A NO20022888A NO20022888D0 NO 20022888 D0 NO20022888 D0 NO 20022888D0 NO 20022888 A NO20022888 A NO 20022888A NO 20022888 A NO20022888 A NO 20022888A NO 20022888 D0 NO20022888 D0 NO 20022888D0
Authority
NO
Norway
Prior art keywords
antibacterial agents
new lipopeptides
lipopeptides
new
antibacterial
Prior art date
Application number
NO20022888A
Other languages
English (en)
Other versions
NO20022888L (no
Inventor
Jason Hill
Ian Parr
Michael Morytko
Jim Siedlecki
Xiang Yang Yu
Jared Silverman
Dennis Keith
John Finn
Dale Christensen
Tsvetelina Lazarova
Alan D Watson
Yan Zhang
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Publication of NO20022888D0 publication Critical patent/NO20022888D0/no
Publication of NO20022888L publication Critical patent/NO20022888L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20022888A 1999-12-15 2002-06-17 Lipopeptider som antibakterielle midler NO20022888L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17094399P 1999-12-15 1999-12-15
PCT/US2000/034118 WO2001044272A2 (en) 1999-12-15 2000-12-15 Daptomycin analogs as antibacterial agents

Publications (2)

Publication Number Publication Date
NO20022888D0 true NO20022888D0 (no) 2002-06-17
NO20022888L NO20022888L (no) 2002-08-02

Family

ID=22621910

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022888A NO20022888L (no) 1999-12-15 2002-06-17 Lipopeptider som antibakterielle midler

Country Status (13)

Country Link
US (2) US6911525B2 (no)
EP (4) EP1240181A2 (no)
JP (2) JP4990456B2 (no)
KR (1) KR20020063227A (no)
CN (1) CN1425025A (no)
AU (1) AU784755B2 (no)
BR (1) BR0017026A (no)
CA (1) CA2393907A1 (no)
IL (2) IL150223A0 (no)
MX (1) MXPA02006029A (no)
NO (1) NO20022888L (no)
WO (1) WO2001044272A2 (no)
ZA (1) ZA200205106B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020063228A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
CA2301336A1 (en) * 2000-03-17 2001-09-17 Michael T. Kelly Topical treatment of rosacea
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
KR20110127732A (ko) 2000-12-18 2011-11-25 큐비스트 파마슈티컬즈 인코포레이티드 정제된 리포펩티드의 제조 방법
EP1423137B1 (en) * 2001-08-06 2009-04-29 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
ES2243763T3 (es) * 2001-08-28 2005-12-01 Pharmacia Corporation Base libre de clindamicina cristalina.
US6767718B2 (en) 2002-05-10 2004-07-27 Biosource Pharm, Inc. Lipodepsipeptide antibiotics and methods of preparation
CA2490062A1 (en) * 2002-05-23 2003-12-04 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
CA2488803C (en) 2002-06-06 2013-08-13 Vicuron Pharmaceuticals Inc. Use of ramoplanin to treat diseases associated with the use of antibiotics
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
ITMI20022076A1 (it) * 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.
US20040132764A1 (en) * 2002-10-23 2004-07-08 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Antibiotics for the treatment of infections in acidic environments
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
RU2007121705A (ru) * 2004-11-12 2008-12-20 Кьюбист Фармасьютикалз Антиинфекционные липопептиды
US20080051326A1 (en) * 2004-11-12 2008-02-28 Alexander Dylan C Antiinfective Lipopeptides
NZ563271A (en) * 2005-04-29 2009-12-24 Cubist Pharm Inc Therapeutic compositions
WO2007127218A2 (en) * 2006-04-26 2007-11-08 Taro Pharmaceuticals U.S.A., Inc. Streptomyces-derived antimicrobial compound and method of using same against antibiotic-resistant bacteria
UA96768C2 (uk) * 2006-08-02 2011-12-12 Йоганес Гутенберг-Універсітет Майнц Лікарський засіб від lct-отруєнь
US20080185010A1 (en) * 2007-02-06 2008-08-07 Kesselman Joshua D Interleaved Transparent Cellulose Paper with Opaque Adhesive
US8584854B2 (en) * 2007-02-06 2013-11-19 BBK Tobacco & Foods, LLP Reclosable package with magnetic clasp and detachable tray for rolling papers used in smoking articles
US8662086B2 (en) 2007-02-06 2014-03-04 BBK Tobacco & Foods, LLP Reclosable package with magnetic clasp for rolling papers used in smoking articles
US20090020443A1 (en) * 2007-05-09 2009-01-22 Kesselman Joshua D Credit Card Carrying Pack for Rolling Papers
US9072319B2 (en) 2007-06-15 2015-07-07 Joshua D. Kesselman Rolling paper structures for creating smoking articles and gummed, coiled inserts for same
US9161572B2 (en) * 2007-06-15 2015-10-20 Bbk Tobacco & Foods, Inc. Structures for creating smoking articles and methods of packaging same
US20090014342A1 (en) * 2007-07-14 2009-01-15 Kesselman Joshua D Rolling papers and methods of packaging same
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
CA2710602A1 (en) * 2007-12-26 2009-07-09 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
US8393332B2 (en) 2008-08-21 2013-03-12 BBK Tobacco & Foods, LLP Packaging for rolling papers for smoking articles
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
ES2442167T3 (es) * 2008-12-22 2014-02-10 Cubist Pharmaceuticals, Inc. Nuevos agentes antibacterianos para el tratamiento de infecciones gram positivas
US8343912B2 (en) 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
ES2374779B1 (es) * 2010-03-10 2012-12-27 Universidad De Barcelona Compuestos péptidicos útiles como agentes antibacterianos.
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CA2806362A1 (en) * 2010-07-23 2012-01-26 Activbiotics Pharma, Llc Administration of rifalazil to immunocompromised patients
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
CN110577581A (zh) * 2018-06-07 2019-12-17 美国蓝博药业公司 一种新型的抑菌脂肽化合物、制备方法及其应用
CN109182563B (zh) * 2018-08-01 2020-07-14 浙江大学 检测20种dfrA类甲氧苄胺嘧啶类药物耐药基因的方法及所用试剂盒
CN113061164B (zh) * 2021-03-29 2023-01-10 四川大学 环脂肽类化合物及其在抗类风湿关节炎药物中的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
AU563067B2 (en) 1982-02-27 1987-06-25 Beecham Group Plc Heterocyclic normonyl derivatives
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4524135A (en) 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4537717A (en) * 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4396543A (en) 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4399067A (en) 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4885243A (en) 1984-10-09 1989-12-05 Eli Lilly And Company Process for producing A-21978C derivatives
ZA857759B (en) 1984-10-09 1987-05-27 Lilly Co Eli Process for the production of a-21978c derivatives
US4874843A (en) 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
EP0460882B1 (en) 1990-06-07 1996-07-24 Eli Lilly And Company Lipopeptide deacylase
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
EP0712405A1 (en) 1993-08-13 1996-05-22 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE544851T1 (de) 1996-03-08 2012-02-15 Astellas Pharma Inc Verfahren zur deacylierung von zyklischen lipopeptiden
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
DK1115417T3 (da) 1998-09-25 2006-07-31 Cubist Pharm Inc Anvendelse af daptomycin
US9393093B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device

Also Published As

Publication number Publication date
JP2003517004A (ja) 2003-05-20
CN1425025A (zh) 2003-06-18
US20020025924A1 (en) 2002-02-28
WO2001044272A3 (en) 2001-11-29
NO20022888L (no) 2002-08-02
AU784755B2 (en) 2006-06-08
JP2012140432A (ja) 2012-07-26
KR20020063227A (ko) 2002-08-01
US6911525B2 (en) 2005-06-28
AU2268201A (en) 2001-06-25
EP1240181A2 (en) 2002-09-18
WO2001044272A2 (en) 2001-06-21
EP2295444A2 (en) 2011-03-16
CA2393907A1 (en) 2001-06-21
EP1884520A3 (en) 2008-03-05
MXPA02006029A (es) 2004-08-23
US20050203006A1 (en) 2005-09-15
US7335725B2 (en) 2008-02-26
EP1884520A2 (en) 2008-02-06
ZA200205106B (en) 2003-09-25
EP2295444A3 (en) 2011-03-23
BR0017026A (pt) 2003-01-07
IL150223A0 (en) 2002-12-01
EP2298790A1 (en) 2011-03-23
IL150223A (en) 2013-09-30
JP4990456B2 (ja) 2012-08-01

Similar Documents

Publication Publication Date Title
NO20022886D0 (no) Nye lipopeptider som antibakterielle midler
NO20022888D0 (no) Nye lipopeptider som antibakterielle midler
NO20022887D0 (no) Lipopeptider som antibakterielle midler
NO20031001D0 (no) Polyarylkarboksamider nyttige som lipidsenkende midler
NO20033715D0 (no) Nye sammensetninger
NO20011738L (no) Heterocyclylaminometyloksazolidinoner som antibakterielle midler
NO20026195D0 (no) Substituerte-triazolopyrimidiner som anticancer midler
NO20014412L (no) Forbindelser nyttige som anti-inflammatoriske midler
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
NO20042955L (no) Substituerte fenylaftalener som estrogene midler
NO20015855L (no) Ny anvendelse av forbindelser som antibakterielle midler
NO20035193L (no) Nye pyrrolderivater som farmas degree ytiske midler
NO20022502L (no) Nye antidiabetiske midler
NO20021329L (no) Kinaseinhibitorer som terapeutiske midler
DK1326858T3 (da) Piperidinforbindelser som anti-allergiske midler
NO20020810L (no) Nye fenylpiperaziner
NO20032272L (no) Bifenylkarboksamider nyttige som lipidsenkende midler
NO20015074L (no) Nye sammensetninger
NO20024745L (no) 2-hydroksymutilinkarbamat-derivater for antibakteriell anvendelse
NO20030100L (no) Pleuromutilinderivater som har antibakteriell aktivitet
DK1246810T3 (da) Piperidinyloxy- og pyrrolidinyloxyphenyloxazolidinoner som antibakterielle midler
DK1181288T3 (da) Bicycliske oxazolidinoner som antibakterielle midler
NO20020621D0 (no) Antibakterielle midler
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
DK1075471T3 (da) Idolylderivater som serotonerge midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application